Pharma Commerce editor takes a look back at 2023’s impressionable editorial content.
A Year in Review
Related Posts
FDA Approves Treatment to Lower Relapse in High-Risk Neuroblastoma
Eflornithine (Iwilfin) is indicated to lower the risk of relapse in adult and pediatric patients with high-risk neuroblastoma who showed at least a partial response […]
Pharmaceutical Commerce – April 2024 Issue (PDF)
Pharmaceutical Commerce – April 2024 Issue (PDF) Cold Chain, PBMs, and More Looking Ahead to LogiPharma Europe An ‘Access’ Double-Take: Fresh Views on PAPs and […]
McKesson, Independent Pharmacy Cooperative Reach Drug Supply Agreement
Adobe Stock Images/Preyanuch.com Independent Pharmacy Cooperative (IPC), a group purchasing organization consisting of community pharmacies, has reached a new supply agreement1 with McKesson, a drug […]